Patent details

Basic Information

Publication number:

EP3802922

PCT Application Number:

US2019036252

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP197400989

PCT Publication Number:

WO2019241098

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NOVEL IMMUNE CHECKPOINT INHIBITORS

French Title of Invention:

NOUVEAUX INHIBITEURS DE POINT DE CONTRÔLE IMMUNITAIRE

German Title of Invention:

NEUE IMMUNCHECK-INHIBITOREN

SPC Number:

Dates

Filing date:

10/06/2019

Grant date:

26/04/2023

EP Publication Date:

14/04/2021

PCT Publication Date:

19/12/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/04/2023

EP B1 Publication Date:

26/04/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/06/2023

Expiration date:

10/06/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/04/2023

 

 

Name:

Boehringer Ingelheim International GmbH

Address:

Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Name:

Yale University

Address:

2 Whitney Avenue, New Haven, CT 06510, United States (US)

Inventor

1

Name:

CHEN, Lieping

Address:

United States (US)

2

Name:

WANG, Jun

Address:

United States (US)

3

Name:

BLAIR, David A.

Address:

United States (US)

4

Name:

ZHENG, Timothy

Address:

United States (US)

Priority

Priority Number:

201862683256 P

Priority Date:

11/06/2018

Priority Country:

United States (US)

Classification

IPC classification:

C40B 30/04; G01N 33/574;

Publication

European Patent Bulletin

Issue number:

202317

Publication date:

26/04/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages